RIO DE JANEIRO, BRAZIL - Hormone replacement is pointed out as a potential treatment for patients suffering from breast cancer, but according to a study published last Thursday, August 29th, in the scientific journal The Lancet, the therapy is, in fact, a direct cause of this tumor.
It is estimated that in Europe alone, some six million women resort to hormone replacement therapy.
The same research alerts that one in every 50 women, of healthy weight, who resort to the most common form of this therapy daily - combined estrogen and progestogen - for at least five years - has a high probability of . . .